We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.50 | 0.58% | 1,810.00 | 1,807.50 | 1,808.50 | 1,809.00 | 1,792.00 | 1,797.00 | 4,235,825 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.10 | 74.42B |
Date | Subject | Author | Discuss |
---|---|---|---|
16/7/2019 12:28 | Yes it would be nice to get back to the £20 days again. I used to trade this. buy around 1750 sell at £20 did it several times then i did a spread at 1750 and it dropped to £10 think i sold about £14 painful but always said if people asked me for a tip around that time buy GSK for a tenner and youll do well. They had a few opportunities to do this. these days its been start buying when it goes to £14 and start selling £15-1550 and get 6% while u wait. Now its broken out who knows | stpalm | |
16/7/2019 11:24 | £1 = $1.24 | tradermichael | |
15/7/2019 16:23 | Upwards and onwards... 1700 next. | sogoesit | |
15/7/2019 14:59 | My target is 1910p if break up. | montyhedge | |
15/7/2019 14:33 | NOW TRADING AT A TWO YEAR HIGH and showing distinct strength. ALL IMO. DYOR. QP | quepassa | |
14/7/2019 08:00 | Hundreds of thousands of CJD cases have been misdiagnosed in the USA as Alzheimer's -------------------- The BBC2 programme , Mad Cow the new new wave las thursaday at 9pm, didn't dare pick up on this, because it was warned off. But it means that 100% of surgical instruments should be tested for protein residue for EVERY type of operation not just neurology and eye surgery and a few others as detailed in DOH HTM 01-01 2016 update , here is why: 2003 '' Now people are beginning to realize that because something looks like sporadic CJD they can't necessarily conclude that it's not linked to (mad cow disease)," said Laura Manuelidis, section chief of surgery in the neuropathology department at Yale University, who conducted a 1989 study that found 13 percent of Alzheimer's patients actually had CJD. Several studies, including the one by Manuelidis, have found autopsies reveal 3-percent-to-13-perc buywell notes In 2003 From the Laura Manuelidis, section chief of surgery in the neuropathology department at Yale University findings in 2003: At her lower end figure of 3% of misdiagnosed Alzheimer's cases which should have been diagnosed as CJD, this works out that there should be a minimum of 120,000 cases a year minimum of CJD being diagnosed. In 2018 5.7 million Americans of all ages are now diagnosed as having Alzheimer’s and now someone in the United States is being diagnosed with Alzheimer’s disease every 65 seconds. Based upon the average range of the studies which misdiagnosed Alzheimer's which should have been diagnosed as CJD ie 3% to 13% , average = 8% The number of people in the USA today that should be diagnosed with a form of CJD is 8% of 5.7M = 456,000. Yes 456,000 of CJD cases in the USA that have at present been wrongly diagnosed as Alzheimer's WHY is this happening and why are CJD cases not been diagnosed correctly ? -------------------- buywell thinks this is because: 1. No piece of test equipment exists that can test for any form of CJD ( at least eight types now exist, more being identified) in a living human being. 2. CJD can at present only be 100% correctly identified by post-mortem 3. CJD is a prion disease always fatal and no cure ... like Alzheimer's. Hospital staff know this and also that it is highly contagious and transmissible disease, they are scared of catching it themselves and rightly so. There is a development in the USA where some state universities are trying to develop a piece of test equipment that will detect CWD in a living deer. ( CWD is a TSE, like BSE, a prion disease in Cervids) One has to ask why is the FDA and USA government not involved or at least funding this ? buywell thinks because such a piece if new test equipment can then be modified to detect CJD in humans and then case numbers will rocket to the hundreds of thousands causing mass panic. | buywell3 | |
11/7/2019 13:31 | Well, taking those in tablet form beats eating dog or snake as a meal in China and Korea, I suppose! | sogoesit | |
11/7/2019 09:21 | Yes, dividend into my Selftrade account this morning :-) | philanderer | |
11/7/2019 09:20 | Very profitable 15-16 trading range of last 2 years fully broken now. Those trading it will be closing/stopped out now imo. 17 is another matter though very tough resistance! | tim 3 | |
11/7/2019 09:20 | yes give him my regards...ho,ho, | lippy4 | |
11/7/2019 09:06 | could always buy a condolance card for Porsche ;) | stevieweebie2 | |
11/7/2019 08:52 | Received my dividends in my AJ Bell accounts today. When to reinvest the £8K in GSK, then? ….. ;0) | tradermichael | |
11/7/2019 07:57 | Brussels (AFP) - The EU on Wednesday approved the merger of the consumer healthcare activities of pharmaceutical giants GlaxoSmithKline and Pfizer that produce over-the-counter medicines. The European Commission, the EU's powerful anti-trust authority, said the decision came after the UK and US companies agreed to divest Pfizer's ThermaCare pain therapy brand. This commitment removes "almost entirely the overlaps between GSK and Pfizer's Consumer Health Business", the commission said. The greenlight is a crucial hurdle for the tie-up of over-the-counter brands with combined sales of 9.8 billion pounds ($12 billion, 11 billion euros) that include GSK's Sensodyne toothpaste and Pfizer's Centrum multivitamins. With the venture, British group GSK is split into two entities, one specialised in the development of drugs and the other in consumer healthcare. | tradermichael | |
10/7/2019 12:36 | Yes, £ v $ has fallen from 1.33 to 1.25 (6%) over past year. Strong new sales growth (e.g. Shingrix) coupled with Sterling's weakness look good for earnings and underpins the dividend ….. ;0) | tradermichael | |
10/7/2019 12:23 | TM, So earnings on the 5% upside? | beckers2008 | |
10/7/2019 12:13 | £1 = US$ 1.25 | tradermichael | |
10/7/2019 01:22 | Just noticed GSK has now taken over from TATE as my largest holding :-) | philanderer | |
09/7/2019 15:45 | yes 8 million cows killed when there was no reason,good old eu in action,i dont think.. love the share price that millionaire was so wrong about it dropping like a stone,hopefully this is the future.. divi day will be the main factor for the future. | lippy4 | |
09/7/2019 13:35 | G2 - don't tempt me!!! | alphorn | |
09/7/2019 12:23 | Mad Cow was tragic for farmers but wonderful for consumers. The shops could hardly give the stuff away so I ate more beef and steak then than at any other time before or since. Needless to say it did me no harm at all. | grahamite2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions